COMMUNIQUÉS West-GlobeNewswire

SPINEWAY : Convocation à l'Assemblée Générale Mixte du 19 septembre 2019
09/09/2019
Convocation à l'Assemblée Générale Mixte du 19 septembre 2019 Modalités de mise à disposition des documents préparatoires L'Assemblée Générale des actionnaires de Spineway, convoquée le 16 août 2019 à 9 heures au siège [...]
Oxurion NV Reports Additional Positive Topline Data from Phase 1 with THR-149, a Novel, Potent Plasma Kallikrein Inhibitor for DME
09/09/2019
Immediate onset of action - starting from Day 1 with increasing average improvement in Best Corrected Visual Acuity (BCVA) of up to 7.5 letters at Day 14 following a single injection of THR-149. Prolonged durability of [...]
GRAChIE Earns Community Partnership Award For Work During Hurricanes Irma and Florence
09/09/2019
Georgia HIE recognized for establishing rapid connections to facilitate access to vital health data SANDERSVILLE, Ga., Sept. 09, 2019 (GLOBE NEWSWIRE) -- The Georgia Regional Academic Community Health Information [...]
Improving Vitamin D level, physical fitness, and body weight may help to reduce health risks in African-American adults
09/09/2019
DALLAS, Sept. 09, 2019 (GLOBE NEWSWIRE) -- An estimated 40% of American adults may be vitamin D deficient. For African-Americans, that number may be nearly double at 76% according to a new study by The Cooper Institute [...]
Holding(s) in Company TR-1: Standard form for notification of major holdings
09/09/2019
LONDON, Sept. 09, 2019 (GLOBE NEWSWIRE) -- TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i [...]
Transactions under Novozymes’ stock buyback program
09/09/2019
Please read the full announcement in the attached PDF Attachment 2019_34_Stock_Buybackprogram_EN
Genmab and Tempus Enter into Strategic Collaboration Agreement
09/09/2019
Media Release Copenhagen, Denmark, September 9, 2019 Genmab and Tempus sign agreement to research and develop novel targets Genmab A/S (Nasdaq: GMAB) announced today that it has entered into a strategic collaboration [...]
Generex Biotechnology Signs Letter of Intent to Acquire 51% in ALTuCELL, Inc. and their Cellular Therapy Product Altsulin® with Patented Microencapsulation Technology for the Treatment of Type I Diabetes Mellitis
09/09/2019
Patented cell encapsulation technology enables cell implantation for therapeutic and regenerative medicine application without immune system rejection Microcapsules formulated with ultra-purified alginates and poly-L- [...]
Medtronic Announces Reimbursement in Germany for MiniMed™ 670G Insulin Pump System for Individuals with Type 1 Diabetes
09/09/2019
DUBLIN, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it has secured reimbursement for the MiniMed™ 670G insulin pump [...]
Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board
09/09/2019
LOS ANGELES, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announces [...]
Therapeutic Solutions International Reports NanoStilbene™ Protects the Immune System from Cancer Chemotherapy
09/09/2019
Newly Discovered Properties of NanoStilbene Potentially Allows Company to Address $3.9 Billion Chemotherapy Induced Neutropenia Market OCEANSIDE, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Therapeutics Solutions [...]
UPDATE - Auxly Announces Receipt of Key Cannabis Oil Sales Licences for Dosecann and Kolab Project
09/09/2019
VANCOUVER, British Columbia, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that its wholly-owned subsidiaries, Dosecann Inc. (“ Dosecann ”) and [...]
NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th
09/09/2019
PITTSBURGH, Sept. 09, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address genetic diseases, [...]
Golden Leaf Holdings Expands Management Team
09/09/2019
Former Nike executive Stan Grissinger named President, Erin Hills promoted to Senior Vice President, Operations TORONTO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden [...]
Zosano Pharma Announces the Presentation of Multiple Positive Datasets from the Qtrypta™ Long-Term Safety Study at the Congress of the International Headache Society
09/09/2019
- Repeated Dosing of Qtrypta Over the Course of One Year Reaffirms Qtrypta is Effective and Well-Tolerated as an Acute Treatment for Migraine - - Efficacy and Safety Profile Consistent in Sub Analyses of Patients Taking [...]
Orthogonal Thinker/EI Announces Kevin Matthews, Former Campaign Director of the Denver Psilocybin Initiative, to Join Senior Executive Team to Further Communications Strategy
09/09/2019
KIHEI, HAWAII, Sept. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Orthogonal Thinker Inc. (“Orthogonal/EI” or the “Company”), a biotech holding and operating company, announced today that Kevin Matthews has joined [...]
Assure Holdings Enters into First In-Network Agreement
09/09/2019
DENVER, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, entered into an agreement with a national [...]
Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation
09/09/2019
Fluidigm Launches Breakthrough RNA Sequencing Library Preparation Workflow, Delivering Substantial Cost Savings and Efficiency SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ [...]
Mateon Partners With WideTrial for Data-Generating Expanded Access Programs in Cancer
09/09/2019
AGOURA HILLS, Calif. and SAN FRANCISCO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc. (OTCQB:MATN), announced today that it has executed agreements with WideTrial Inc. for an Expanded Access program (EAP) [...]

Pages